$6.75B
$9.45 Million
0.0% of portfolio
242,028
Q2 2024
Reduced 25.39%
$2.99B
$8 Million
0.0% of portfolio
1,147,504
Q2 2024
Reduced 23.64%
$200M
$117,000
0.0% of portfolio
11,080
Q2 2024
New
$5.63B
$898,000
0.0% of portfolio
9,928
Q2 2024
Added 50.24%
$1.61B
$3.54 Million
0.0% of portfolio
151,066
Q2 2024
New
$1.03B
$579,000
0.0% of portfolio
21,082
Q2 2024
Reduced 8.2%
$24.2B
$1.43 Million
0.0% of portfolio
10,031
Q2 2024
Added 0.15%
$5.04B
$761,000
0.0% of portfolio
8,116
Q2 2024
Reduced 10.14%
$8.34B
$1.22 Million
0.0% of portfolio
21,433
Q2 2024
Reduced 37.95%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 99.55%
$1.16B
$216,000
0.0% of portfolio
9,502
Q2 2024
Reduced 5.69%
-
$0
0.0% of portfolio
-
Q2 2024
Added 0.98%
$188M
$986,000
0.0% of portfolio
653,570
Q2 2024
Added 6,435.7%
$412M
$247,000
0.0% of portfolio
30,744
Q2 2024
Added 147.9%
$5.53B
$5.37 Million
0.0% of portfolio
101,959
Q2 2024
Reduced 19.49%
$8.3B
$8.91 Million
0.0% of portfolio
32,622
Q2 2024
Reduced 1.18%
$85.3M
$553,000
0.0% of portfolio
404,198
Q2 2024
Added 55.06%
$1.38B
$84,000
0.0% of portfolio
13,723
Q2 2024
New
Biomarin Pharmaceutical Inc
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 99.43%
Biomarin Pharmaceutical Inc
-
$0
0.0% of portfolio
-
Q2 2024
Added 117.78%
$29.1B
$1.06 Million
0.0% of portfolio
13,226
Q2 2024
Reduced 7.67%
$720M
$768,000
0.0% of portfolio
133,641
Q2 2024
New
$15.4M
$40,000
0.0% of portfolio
31,308
Q2 2024
Reduced 25.65%
$406M
$93,000
0.0% of portfolio
36,268
Q2 2024
Reduced 57.06%
$11.6B
$1.35 Million
0.0% of portfolio
15,407
Q2 2024
Added 2.15%
$144M
$133,000
0.0% of portfolio
28,593
Q2 2024
New
$3.9B
$1.06 Million
0.0% of portfolio
19,581
Q2 2024
Reduced 31.88%
$4.35B
$1.1 Million
0.0% of portfolio
14,393
Q2 2024
Reduced 0.06%
$1.34B
$4.3 Million
0.0% of portfolio
1,733,809
Q2 2024
Added 32.68%
$3.22B
$8.88 Million
0.0% of portfolio
183,201
Q2 2024
Added 28.4%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 51.7%
$0
$1.13 Million
0.0% of portfolio
87,083
Q2 2024
Reduced 0.01%
$0
$140,000
0.0% of portfolio
11,773
Q2 2024
Reduced 33.68%
$0
$212,000
0.0% of portfolio
18,540
Q2 2024
Reduced 35.11%
$0
$212,000
0.0% of portfolio
20,788
Q2 2024
Reduced 34.88%
$0
$214,000
0.0% of portfolio
19,803
Q2 2024
Reduced 34.76%
$0
$208,000
0.0% of portfolio
18,319
Q2 2024
Reduced 35.24%
$0
$220,000
0.0% of portfolio
21,598
Q2 2024
Reduced 33.75%
$0
$218,000
0.0% of portfolio
20,101
Q2 2024
Reduced 34.08%
$0
$211,000
0.0% of portfolio
18,525
Q2 2024
Reduced 34.96%
$0
$348,000
0.0% of portfolio
28,360
Q2 2024
Reduced 34.02%
$0
$449,000
0.0% of portfolio
27,467
Q2 2024
New
$3.12B
$887,000
0.0% of portfolio
50,967
Q2 2024
Added 70.58%
$4.86B
$481,000
0.0% of portfolio
15,717
Q2 2024
Added 5.42%
$234M
$67,000
0.0% of portfolio
19,298
Q4 2023
Reduced 23.01%
$811M
$202,000
0.0% of portfolio
85,847
Q2 2024
New
$90.5M
$604,000
0.0% of portfolio
220,549
Q2 2024
Reduced 21.08%
$9.91B
$1.33 Million
0.0% of portfolio
24,467
Q2 2024
Added 1.04%
-
$0
0.0% of portfolio
-
Q1 2024
New
$1.91B
$5.54 Million
0.0% of portfolio
452,946
Q2 2024
Reduced 14.48%